diphtheria, tetanus and pertussis vaccine infant (DTcP infant)
/ CanSino
- LARVOL DELTA
Home
Next
Prev
1 to 9
Of
9
Go to page
1
October 03, 2025
Clinical Trial of the Adsorbed Acellular Pertussis (Tricomponent) DTaP-Haemophilus Influenzae Type b (Conjugate)-ACYW135 Group Meningococcal (Conjugate) Combined Vaccine
(clinicaltrials.gov)
- P1 | N=260 | Not yet recruiting | Sponsor: CanSino Biologics Inc.
New P1 trial • CNS Disorders • Infectious Disease • Influenza • Meningococcal Infections • Pertussis • Respiratory Diseases • Tetanus
August 16, 2025
Inter-lot Consistency Clinical Trial of Adsorbed Cell-free DTP (Three-component) Combined Vaccine
(clinicaltrials.gov)
- P3 | N=780 | Active, not recruiting | Sponsor: CanSino Biologics Inc. | Recruiting ➔ Active, not recruiting
Enrollment closed • Infectious Disease • Pertussis • Respiratory Diseases • Tetanus
March 31, 2025
Inter-lot Consistency Clinical Trial of Adsorbed Cell-free DTP (Three-component) Combined Vaccine
(clinicaltrials.gov)
- P3 | N=780 | Recruiting | Sponsor: CanSino Biologics Inc. | Not yet recruiting ➔ Recruiting
Enrollment open • Infectious Disease • Pertussis • Respiratory Diseases • Tetanus
March 17, 2025
A Clinical Trial of Diphtheria, Tetanus and Acellular Pertussis (Three Components) Combined Vaccine, Adsorbed(DTcP)
(clinicaltrials.gov)
- P3 | N=2520 | Active, not recruiting | Sponsor: CanSino Biologics Inc. | Trial completion date: Aug 2024 ➔ Apr 2025 | Trial primary completion date: Aug 2024 ➔ Apr 2025
Trial completion date • Trial primary completion date • Infectious Disease • Pertussis • Respiratory Diseases • Tetanus
March 04, 2025
Inter-lot Consistency Clinical Trial of Adsorbed Cell-free DTP (Three-component) Combined Vaccine
(clinicaltrials.gov)
- P3 | N=780 | Not yet recruiting | Sponsor: CanSino Biologics Inc.
New P3 trial • Infectious Disease • Pertussis • Respiratory Diseases • Tetanus
March 26, 2024
A Clinical Trial of Diphtheria, Tetanus and Acellular Pertussis (Three Components) Combined Vaccine, Adsorbed(DTcP)
(clinicaltrials.gov)
- P3 | N=2520 | Active, not recruiting | Sponsor: CanSino Biologics Inc. | Recruiting ➔ Active, not recruiting | Trial primary completion date: Feb 2024 ➔ Aug 2024
Enrollment closed • Trial primary completion date • Infectious Disease • Pertussis • Respiratory Diseases • Tetanus
August 16, 2023
A Clinical Trial of Diphtheria, Tetanus and Acellular Pertussis (Three Components) Combined Vaccine, Adsorbed(DTcP)
(clinicaltrials.gov)
- P3 | N=2520 | Recruiting | Sponsor: CanSino Biologics Inc. | Not yet recruiting ➔ Recruiting
Enrollment open • Infectious Disease • Pertussis • Respiratory Diseases • Tetanus
July 20, 2023
A Clinical Trial of Diphtheria, Tetanus and Acellular Pertussis (Three Components) Combined Vaccine, Adsorbed(DTcP)
(clinicaltrials.gov)
- P3 | N=2520 | Not yet recruiting | Sponsor: CanSino Biologics Inc.
New P3 trial • Infectious Disease • Pertussis • Respiratory Diseases • Tetanus
October 31, 2022
PICTDTOV: Phase I Clinical Trial of Diphtheria, Tetanus and Acellular Pertussis (Three Components) Combined Vaccine, Adsorbed .
(clinicaltrials.gov)
- P1 | N=400 | Completed | Sponsor: CanSino Biologics Inc. | Unknown status ➔ Completed
Trial completion • Infectious Disease • Pertussis • Respiratory Diseases • Tetanus
1 to 9
Of
9
Go to page
1